Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
J William Beakey, OMD
J. William Beakey is a licensed doctor of Oriental medicine, researcher and the founder and director of Professional Co-op, a laboratory service that exclusively serves licensed clinicians. For more information, visit www.ProfessionalCo-op.com.